News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Emergent BioSolutions Provides Preliminary 2010 Financial Results and Guidance for 2011
January 10, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
(BUSINESS WIRE)--Emergent BioSolutions Inc. announced today preliminary, unaudited financial results for 2010 and guidance for 2011.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Emergent BioSolutions
MORE ON THIS TOPIC
Pipeline
Pfizer culls early PD-L1 asset after series of clinical wins, deals in cancer
April 24, 2026
·
2 min read
·
Tristan Manalac
IPO tracker
Avalyn seeks public debut to support new lung drug formulations
April 24, 2026
·
11 min read
·
Editorial Team
Deals
Amneal inks $1.1B Kashiv buyout to pursue biosimilar market leadership
April 23, 2026
·
2 min read
·
Nick Paul Taylor
Leadership
BBOT shakes up leadership as RAS competitors get more visibility
April 23, 2026
·
2 min read
·
Annalee Armstrong
